CL2018003484A1 - Composición de virus y método para separación que usa la misma. - Google Patents

Composición de virus y método para separación que usa la misma.

Info

Publication number
CL2018003484A1
CL2018003484A1 CL2018003484A CL2018003484A CL2018003484A1 CL 2018003484 A1 CL2018003484 A1 CL 2018003484A1 CL 2018003484 A CL2018003484 A CL 2018003484A CL 2018003484 A CL2018003484 A CL 2018003484A CL 2018003484 A1 CL2018003484 A1 CL 2018003484A1
Authority
CL
Chile
Prior art keywords
separation
virus composition
composition
molibden
virus
Prior art date
Application number
CL2018003484A
Other languages
English (en)
Inventor
Mitsuo Yamashita
Akira Miura
Original Assignee
Jx Nippon Mining & Metals Corp
Shibaura Inst Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jx Nippon Mining & Metals Corp, Shibaura Inst Tech filed Critical Jx Nippon Mining & Metals Corp
Publication of CL2018003484A1 publication Critical patent/CL2018003484A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P3/00—Preparation of elements or inorganic compounds except carbon dioxide
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2257/00—Components to be removed
    • B01D2257/60—Heavy metals or heavy metal compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00041—Use of virus, viral particle or viral elements as a vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14111—Inoviridae
    • C12N2795/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14111—Inoviridae
    • C12N2795/14131—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P10/00—Technologies related to metal processing
    • Y02P10/20—Recycling

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PROPORCIONAR UN MÉTODO PARA SELECCIONAR MINERAL DE MOLIBDENO. (MEDIOS PARA RESOLVER LOS PROBLEMAS) COMPOSICIÓN QUE COMPRENDE FAGO M13 PARA SEPARAR UNA SUSTANCIA QUE CONTIENE MOLIBDENO.
CL2018003484A 2016-06-06 2018-12-05 Composición de virus y método para separación que usa la misma. CL2018003484A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016112987A JP6865925B2 (ja) 2016-06-06 2016-06-06 ウイルス組成物及びそれを用いた分離方法

Publications (1)

Publication Number Publication Date
CL2018003484A1 true CL2018003484A1 (es) 2019-02-22

Family

ID=60577818

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018003484A CL2018003484A1 (es) 2016-06-06 2018-12-05 Composición de virus y método para separación que usa la misma.

Country Status (8)

Country Link
US (1) US10954531B2 (es)
JP (1) JP6865925B2 (es)
CN (1) CN109312369B (es)
AU (1) AU2017278423B2 (es)
CA (1) CA3026796C (es)
CL (1) CL2018003484A1 (es)
PE (1) PE20190182A1 (es)
WO (1) WO2017213152A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6935876B2 (ja) 2016-06-06 2021-09-15 学校法人 芝浦工業大学 新規ペプチド及びその利用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3277532B2 (ja) 1992-01-21 2002-04-22 住友金属鉱山株式会社 モリブデン鉱物の精製方法
JPH10338700A (ja) 1997-06-09 1998-12-22 Kanegafuchi Chem Ind Co Ltd 新規ペプチド化合物
JP4834789B2 (ja) 2009-05-22 2011-12-14 パナソニック株式会社 フェリチンの配置方法
JP5936573B2 (ja) 2013-03-27 2016-06-22 国立大学法人九州大学 銅とモリブデンの分離方法
JP2015224225A (ja) * 2014-05-28 2015-12-14 京セラ株式会社 金属化合物吸着材およびそれを用いた金属化合物の回収方法
JP2016047810A (ja) * 2014-08-26 2016-04-07 株式会社デンソー ペプチド、希土類元素回収材、及び希土類元素の回収方法
JP6935876B2 (ja) 2016-06-06 2021-09-15 学校法人 芝浦工業大学 新規ペプチド及びその利用方法
CN106565826B (zh) * 2016-11-08 2020-03-20 华东理工大学 大肠杆菌o157：h7亲和十二肽及其筛选方法和应用

Also Published As

Publication number Publication date
US10954531B2 (en) 2021-03-23
CA3026796C (en) 2023-09-05
CN109312369B (zh) 2022-08-23
CN109312369A (zh) 2019-02-05
WO2017213152A1 (ja) 2017-12-14
CA3026796A1 (en) 2017-12-14
US20190309325A1 (en) 2019-10-10
JP6865925B2 (ja) 2021-04-28
JP2017216920A (ja) 2017-12-14
AU2017278423B2 (en) 2019-10-31
PE20190182A1 (es) 2019-02-01
AU2017278423A1 (en) 2019-01-03

Similar Documents

Publication Publication Date Title
CL2021001179A1 (es) Anticuerpos específicos para tl1a y ácidos nucleicos que los codifican (divisional de la solicitud no. 201801596).
CO2019003154A2 (es) Anticuerpos anti-pd-1 y sus usos
CR20180564A (es) Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que lo contienen
SV2018005709A (es) 3-azabiciclo[3.1.0]hexanos sustituidos como inhibidores de cetohexoquinasa
CL2018000490A1 (es) Anticuerpos anti-pd1 y sus métodos de uso
SV2018005684A (es) Anticuerpos que se unen especificamente a pd-1 y sus usos
MX2017015464A (es) Anticuerpos anti-tau y metodos de uso.
UY37523A (es) Anticuerpos anti-ox40 y sus usos
CR20160500A (es) Anticuerpos anti-ox40 y métodos de uso
CL2018001156A1 (es) Preparación de muestras para muestras difíciles.
MX2017014136A (es) Anticuerpos anti-cd166, anticuerpos anti-cd166 activables, y metodos de uso de los mismos.
MX2024011869A (es) Anticuerpos anti-tau y metodos de uso
MX2018005528A (es) Inhibidores de ret.
ECSP17023281A (es) Inhibidores de mk2 y sus usos
MX391171B (es) Anticuerpos anti-cd19 humano con alta afinidad
CL2017001461A1 (es) Composiciones y métodos para anticuerpos que se marcan bmp6
CL2015002738A1 (es) Xantinas sustituidas y métodos de uso de las mismas.
DK3067817T3 (da) Dynamisk data-maskering til mainframe-applikation
MX2016016886A (es) Anticuerpos anti-axl.
CR20140534A (es) Proceso para la preparación de treprostinil y derivado de los mismos
MX2022000053A (es) Moduladores de interaccion de sestrina-gator2 y sus usos.
CL2018001837A1 (es) Compuestos antiproliferativos y sus composiciones farmacéuticas y usos
MX2017013875A (es) Ciertos inhibidores de la proteína quinasa.
AR109685A1 (es) Composiciones de nanopartículas y métodos para fabricarlas y usarlas
PE20180171A1 (es) Neutralizacion del virus chikungunya mediada por anticuerpos